News

Dividend investors don't like payout decreases or suspensions, hence the importance of finding companies that are unlikely to resort to these moves. But that's not always easy.

There are plenty of

Verizon Communications (NYSE: VZ) shares currently yield roughly 6.6%. Investors are often attracted to high-yield stocks for their income potential. However, high dividend yields can sometimes be a

Broadcom (NASDAQ: AVGO) continues to stand out among tech stocks for its dividend. During its earnings announcement for the fourth quarter of 2023, it announced what has become an annual payout

Pharmaceutical giant AbbVie (NYSE: ABBV) is undergoing significant changes. Last year, the company lost U.S. patent exclusivity for its biggest cash cow, immunosuppressant Humira, and is now seeing

Chilean lithium giant Sociedad Quimica y Minera de Chile (NYSE: SQM), or SQM, released lower-than-expected fourth-quarter 2023 revenue and earnings results on Wednesday night. The biggest driver for

Valued at more than $2.2 trillion right now, the cryptocurrency market appears to be leaving the so-called crypto winter behind. Thanks to surging optimism, especially for top digital assets like Bi

Walmart (NYSE: WMT) surprised many investors when it announced a stock split in late January. Stock splits are most common when share prices are nearing over $1,000, not when a stock trades for

Artificial intelligence stocks are trading at incredibly high prices right now, and it's not clear that any of the companies involved have a big moat. But if AI is indeed a long-term growth driver

On Tuesday, Viking Therapeutics (NASDAQ: VKTX), a clinical-stage biotech specializing in treatments for metabolic diseases, saw its stock price surge by a staggering 121% in response to a clinical

Duolingo (NASDAQ: DUOL) stock gained 22.1% in Wednesday's after-hours trading, following the educational technology company's release of a strong fourth-quarter 2023 report.

The stock's big rise is

Fiverr International (NYSE: FVRR) shares slipped 14% in value after the company reported fourth-quarter earnings last week. As one might expect, most of the news failed to meet the market's

Most successful investing is slow, tedious, and takes years ... and that's OK. But every now and then, an exception comes along. Artificial intelligence (AI) chip company Nvidia (NASDAQ: NVDA) could

Super Micro Computer (NASDAQ: SMCI) has been the best stock to own in 2024, with few exceptions. So far, it has essentially tripled just two months into the year.

This rise has caused it to cross

Nvidia's (NASDAQ: NVDA) artificial intelligence (AI)-fueled rally was put to the test on the stock market on Feb. 21 when it released its results for the fourth quarter of fiscal 2024 (which ended

Shares of Lowe's (NYSE: LOW) have been on quite a run lately. The company's stock price has jumped more than 10% in just the last month. Yet one Wall Street analyst thinks it needs to go up by

Walmart (NYSE: WMT) is one of the largest, most widely followed stocks on the market, yet it still manages to surprise Wall Street from time to time. Investors got an example of this when the

Developments in artificial intelligence (AI) are playing a major role in overall market dynamics right now. Last year, the tech-heavy Nasdaq Composite soared more than 40% thanks in large part to

NextEra Energy Partners (NYSE: NEP) has increased its distribution annually for nine consecutive years. That puts it on the cusp of achieving the key milestone of a decade. At this point, management

The weight loss drug market is growing in leaps and bounds -- and today the biggest winners are Eli Lilly and Novo Nordisk. These big pharma companies are bringing in billions thanks to their drugs

RTX (NYSE: RTX) hasn't gotten much love from Wall Street lately. The defense and aerospace company is dealing with the fallout of an expensive Pratt and Whitney aircraft engine defect. Contaminated

There are certain benefits to retiring along with a spouse. For one thing, you won't have to go through that transition alone -- you'll have your life partner for support. From there, you'll have

Just one day after the ascendant biotech CRISPR Therapeutics (NASDAQ: CRSP) reported its fourth-quarter earnings on Feb. 21, Chardan Capital analyst Geulah Livshits raised her price target for the